digraph Protocol {
    rankdir=TB;

    // Population nodes
    InitialPop [label="Initial Population" shape=box style=rounded color=green fontcolor=green comment="All patients currently prescribed GLP-1 receptor agonists, including but not limited to medications such as liraglutide, exenatide, dulaglutide, semaglutide, and albiglutide."];
    SubsetScreen [label="Subset Considered for Screening" shape=box style=rounded color=green fontcolor=green comment="Patients from the initial population who have been on GLP-1 medications for a minimum duration of 4 weeks and have not had a documented side effect screening in the past 3 months."];
    Exclusion [label="Exclusion Criteria" shape=box style=rounded color=green fontcolor=green comment="Patients with documented allergies or contraindications to GLP-1 medications, who have discontinued GLP-1 medications within the last 4 weeks, currently participating in a clinical trial involving GLP-1 medications where side effect monitoring is already being conducted, or with a terminal illness or in palliative care."];
    Diagnostic [label="Diagnostic Interventions" shape=box style=rounded color=green fontcolor=green comment="Conduct a comprehensive review of the patient's medical history and current symptoms, administer a standardized questionnaire to assess common side effects, and perform necessary laboratory tests if indicated by symptoms."];
    SuccessfulScreen [label="Conditions for Successful Screens" shape=box style=rounded color=green fontcolor=green comment="Identification and documentation of any side effects, clear communication of findings, recommendation for consultation with a healthcare provider, and follow-up plan established."];

    // Criterion nodes
    MinDuration [label="Min Duration 4 Weeks" shape=ellipse color=blue fontcolor=blue comment="Patients from the initial population who have been on GLP-1 medications for a minimum duration of 4 weeks."];
    NoRecentScreen [label="No Recent Screening" shape=ellipse color=blue fontcolor=blue comment="Patients who have not had a documented side effect screening in the past 3 months."];
    NoAllergies [label="No Allergies" shape=ellipse color=blue fontcolor=blue comment="Patients with documented allergies or contraindications to GLP-1 medications."];
    NotDiscontinued [label="Not Discontinued" shape=ellipse color=blue fontcolor=blue comment="Patients who have discontinued GLP-1 medications within the last 4 weeks."];
    NotInTrial [label="Not in Trial" shape=ellipse color=blue fontcolor=blue comment="Patients currently participating in a clinical trial involving GLP-1 medications where side effect monitoring is already being conducted."];
    NotTerminal [label="Not Terminal" shape=ellipse color=blue fontcolor=blue comment="Patients with a terminal illness or in palliative care where the focus is on comfort rather than active management of medication side effects."];

    // Edges
    InitialPop -> MinDuration [label="if" color=blue fontcolor=blue];
    MinDuration -> NoRecentScreen [label="and" color=blue fontcolor=blue];
    NoRecentScreen -> SubsetScreen [label="then" color=blue fontcolor=blue];

    SubsetScreen -> NoAllergies [label="if" color=blue fontcolor=blue];
    NoAllergies -> NotDiscontinued [label="and" color=blue fontcolor=blue];
    NotDiscontinued -> NotInTrial [label="and" color=blue fontcolor=blue];
    NotInTrial -> NotTerminal [label="and" color=blue fontcolor=blue];
    NotTerminal -> Exclusion [label="then" color=blue fontcolor=blue];

    Exclusion -> Diagnostic [label="if" color=blue fontcolor=blue];
    Diagnostic -> SuccessfulScreen [label="then" color=blue fontcolor=blue];
}